03:50 AM EDT, 04/13/2026 (MT Newswires) -- Michael Thomas Henderson, Director, Chief Executive Officer, on April 08, 2026, sold 20,000 shares in Apogee Therapeutics ( APGE ) for $1,651,664. Following the Form 4 filing with the SEC, Henderson has control over a total of 1,132,987 common shares of the company, with 1,132,987 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1974640/000110465926042155/xslF345X05/tm2611503-1_4seq1.xml